A Phase 1 Clinical Trial DHP2306R1 and DHP2306R2 in Healthy Adult Volunteers
- First Posted Date
- 2024-05-02
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT06395155
- Locations
- 🇰🇷
Chungbuk National University Hospital, Chungbuk, Korea, Republic of
Phase 1 Study of DHP2302R1 and DHP2302R2 in Healthy Adult Volunteers
- First Posted Date
- 2024-03-19
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT06318845
- Locations
- 🇰🇷
H Plus Yangji Hospital, Seoul, Gwanak-gu, Korea, Republic of
Food Effect on Pharmacokinetics and Safety of DHP107 (Liporaxel®) FEEL Study
- Conditions
- Advanced Solid Tumor
- Interventions
- Drug: DHP107(Oral paclitaxel)
- First Posted Date
- 2020-12-19
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 25
- Registration Number
- NCT04675528
- Locations
- 🇭🇺
National Institute of Oncology, Budapest, Hungary
🇭🇺University of Semmelweis, 1st Internal Medicine Clinic, Department of Clinical Pharmacology, Budapest, Hungary
🇭🇺University of Debrecen-Clinical Center, Internal Medicine Clinic, Department of Clinical Pharmacology, Debrecen, Hungary
Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer
- Conditions
- Recurrent or Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2017-10-30
- Last Posted Date
- 2024-02-16
- Lead Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT03326102
- Locations
- 🇺🇸
University of California San Francisco (UCSF), San Francisco, California, United States
🇨🇿Onkologicky stacionar, NH Hospital a.s., nemocnice Horovice (NHH), Hořovice, K Nemocnici, Czechia
🇨🇿Onkologicka klinika, Fakultni nemocnice Olomouc (OUH), Olomouc, I.P. Pavlova 6, Czechia
Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy
- Conditions
- Recurrent or Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2017-10-20
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 549
- Registration Number
- NCT03315364
- Locations
- 🇨🇳
The First Affiliated Hospital Of Hainan Medical College, Haikou, Hainan, China
🇨🇳Anhui Cancer Hospital, Hefei, Anhui, China
🇧🇬Medical Center Nadezhda Clinical" Ltd.,, Sofia, Bulgaria
Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)
- Conditions
- Mild-moderate Alzheimer's Disease
- Interventions
- First Posted Date
- 2017-02-16
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 180
- Registration Number
- NCT03055741
- Locations
- 🇰🇷
Chonnam National University Hospital, Gwangju-si, Jeollanam-do, Korea, Republic of
🇰🇷The Catholic University of Korea, Bucheon, ST. Mary's Hospital, Bucheon-si, Gyeonggi-do, Korea, Republic of
🇰🇷Myongji Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of
A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer
- First Posted Date
- 2016-09-07
- Last Posted Date
- 2017-02-13
- Lead Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT02890511
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Phase 3 Study to Compare Efficacy and Safety of DHP107 vs. Taxol® in Patients With Metastatic or Recurrent Gastric Cancer
- First Posted Date
- 2013-04-25
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Target Recruit Count
- 238
- Registration Number
- NCT01839773
- Locations
- 🇰🇷
Yonsei University Gangnam Severance Hospital, Seoul, Korea, Republic of
🇰🇷Yonsei University Severance Hospital, Seoul, Korea, Republic of
🇰🇷Inje University Haeundae Paik Hospital, Busan, Korea, Republic of